Cordant Inc’s Halozyme HALO Stock Holding History

Cordant Inc’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-34	Closed	-$1K	–	562
2022 Q1	$1K	Buy	+34	New	+$1.21K	﹤0.01%	960

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cordant Inc's HALO Position: Q2 2022 in Review

Cordant Inc sold out of Halozyme (HALO) in Q2 2022, closing a stake of 34 shares — an estimated $1K sold.

Cordant Inc first reported a position in HALO in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

Cordant Inc reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 34 Halozyme shares in Q2 2022, an estimated $1K.
Cordant Inc first reported a position in Halozyme in Q1 2022 and held it in 1 quarter.
Cordant Inc's Halozyme position peaked at $1K in Q1 2022.
367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.